Michel Azizi
Université Paris Descartes
Faculté de Médecine
Paris
France
Name/email consistency: high
- Thromboangiitis obliterans and endothelial function. Azizi, M., Boutouyrie, P., Bura-Rivière, A., Peyrard, S., Laurent, S., Fiessinger, J.N. Eur. J. Clin. Invest. (2010)
- Direct renin inhibition: clinical pharmacology. Azizi, M. J. Mol. Med. (2008)
- Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins exretion in man. Azizi, M., Emanueli, C., Peyrard, S., Maddedu, P., Alhenc-Gelas, F., Campbell, D.J. J. Hypertens. (2008)
- Renin inhibition: the next step in suppression of the renin-angiotensin system?. Azizi, M. Curr. Hypertens. Rep. (2007)
- Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans. Azizi, M., Bissery, A., Peyrard, S., Guyene, T.T., Ozoux, M.L., Floch, A., Ménard, J. Clin. Pharmacol. Ther. (2006)
- Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study. Azizi, M., Ménard, J., Peyrard, S., Lièvre, M., Marre, M., Chatellier, G. Diabetes. Care (2006)
- Renin inhibition. Azizi, M. Curr. Opin. Nephrol. Hypertens. (2006)